Status:

UNKNOWN

Mentalization Based Treatment - Introductory (MBT-I) Group for Male Prisoners With Borderline and/or Antisocial Personality Disorder

Lead Sponsor:

NHS Greater Glasgow and Clyde

Conditions:

Borderline Personality Disorder (BPD)

Antisocial Personality Disorder (ASPD)

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

Established evidence base with MBT for treatment of Borderline Personality Disorder (BPD) and/or Antisocial Personality Disorder (ASPD). Demographic information of United Kingdom prison population hig...

Eligibility Criteria

Inclusion

  • Primary diagnosis of BPD and/or ASPD
  • Co-morbidity with other personality disorder is accepted
  • Sentenced prisoners with estimated date of liberation \> six months

Exclusion

  • Co-morbid severe and enduring mental illness (schizophrenia, delusional disorder, bipolar affective disorder, major depressive disorder)
  • Co-morbid organic brain disorder (acquired brain injury, alcohol related brain damage)
  • Remand prisoners
  • Uncontrolled substance dependence
  • Index offence of sexual offending
  • Repeatedly chaotic, antisocial or violent behaviour in prison
  • Care in segregation and reintegration unit in past 3 months
  • Current individual specialist psychological therapy in prison
  • English as not first language

Key Trial Info

Start Date :

August 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04033835

Start Date

August 1 2019

End Date

August 1 2021

Last Update

July 26 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NHS Greater Glasgow and Clyde

Glasgow, United Kingdom